What are trials? This is a primer, adopted from our upcoming experimentation toolkit, answering a few basic questions on trials.
Last December we co-hosted our winter Research Meeting at Harvard Business School, together with Professors Karim Lakhani and Rembrand Koning. Over 50 researchers were welcomed for a day packed with eight presentations of early-stage, ongoing and completed randomised controlled trials (RCTs).
What prevents government agencies from making a greater use of randomised controlled trials (RCTs), as well as evidence to inform their policies? Last summer we set out to answer this question, and to try and tease out which barrier is the most important. In this blog we present the results from our survey.
IGL is undertaking a study on the barriers that prevent organisations from using randomised controlled trials to evaluate programmes and, more generally, using evidence to inform policies. Take part in our survey to give us your perspective.
As more and more governments attempt to base their policies on sound evidence, randomised controlled trials - the 'gold standard' in evaluation - are gaining a stronger role in determining which policies work. But are they really the best way to tell us which policies should be used? This blogpost explores how to improve our ability to learn and better design things that work.